TY - JOUR T1 - Risk of hospitalization and risk of death for healthcare workers with COVID-19 in nine European Union/European Economic Area countries, January 2020–January 2021 JF - medRxiv DO - 10.1101/2021.03.01.21252651 SP - 2021.03.01.21252651 AU - Lisa Ferland AU - Joana Gomes Dias AU - Carlos Carvalho AU - Cornelia Adlhoch AU - Carl Suetens AU - Julien Beauté AU - Pete Kinross AU - Diamantis Plachouras AU - Favelle Lamb AU - Tuula Hannila-Handelberg AU - Massimo Fabiani AU - Flavia Riccardo AU - Joël Mossong AU - Anne Vergison AU - Rianne van Gageldonk-Lafeber AU - Anne Teirlinck AU - Jackie Melillo AU - Tanya Melillo AU - Piers Mook AU - Richard Pebody AU - Ana Paula Coutinho Rehse AU - Dominique L. Monnet Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/08/2021.03.01.21252651.abstract N2 - We assessed the impact of COVID-19 on healthcare workers (HCWs) from data on 2.9 million cases reported from nine countries in the EU/EEA. Compared to non-HCWs, HCWs had a higher adjusted risk of hospitalization (IRR 3.0 [95% CI 2.2-4.0]), but not death (IRR 0.9, 95% CI 0.4-2.0).Article Summary Line Healthcare workers are hospitalized more frequently than non-healthcare workers when adjusting for age, sex, and comorbidities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementECDC and WHO internal fundsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This manuscript evaluates de-identified public health surveillance data. Actions taken for public health or clinical purposes, and not for research purposes, are not research procedures and do not require IRB approval before being implemented.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are publicly available through https://www.ecdc.europa.eu ER -